about
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of HypothyroidismHyperthyroidism (primary)Hyperthyroidism (primary).A placebo-controlled, blinded and randomised study on the effects of recombinant human thyrotropin on quality of life in the treatment of thyroid cancer.Hyperthyroidism in pregnancyMethylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency.Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study.Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid ArteriesSelenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trialHigh prevalence of papillary thyroid microcarcinoma in danish patients: a prospective study of 854 consecutive patients with a cold thyroid nodule undergoing fine-needle aspirationAssociation between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves' Disease Study.The dose of levothyroxine in pregnant women with hypothyroidism should be increased by 20-30% in the first trimester.Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment - Data Using a Blind, Randomized, Clinical Study.Neither Baseline nor Changes in Serum Triiodothyronine during Levothyroxine/Liothyronine Combination Therapy Predict a Positive Response to This Treatment Modality in Hypothyroid Patients with Persistent Symptoms.131I treatment of nodular non-toxic goitre.Radioiodine therapy increases the risk of cerebrovascular events in hyperthyroid and euthyroid patients.Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends?Large discrepancy in the results of sensitive measurements of thyroglobulin antibodies in the follow-up on thyroid cancer: a diagnostic dilemma.Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study.Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules.A Prospective Comparative Study of Parathyroid Dual-Phase Scintigraphy, Dual-Isotope Subtraction Scintigraphy, 4D-CT, and Ultrasonography in Primary Hyperparathyroidism.Long-term follow-up of thyroid scintigraphies after 131I therapy of solitary autonomous thyroid nodules.Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter.[Problems in thyroid function screening using thyroid stimulating hormone. A case of thyrotoxicosis caused by a thyroid stimulating hormone-secreting pituitary tumor].[Diagnostic strategy of incidental findings of focal thyroid FDG uptake identified on PET/CT]Association between 3-Iodothyronamine (T1AM) Concentrations and Left Ventricular Function in Chronic Heart FailureHow should thyroid-related quality of life be assessed? Recalled patient-reported outcomes compared with here-and-now measuresLevothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?US-guided fine-needle aspiration biopsy of thyroid nodulesA simple procedure for routine RNA extraction and miRNA array analyses from a single thyroidin vivofine needle aspirateLong-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention studyPredictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves' Hyperthyroidism: The RISG StudyTransitory blindness after retrobulbar irradiation of Graves' ophthalmopathy[Combination therapy of thyroxine and triiodothyronine in hypothyroid patients][Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?]Improvement of upper airway obstruction after 131I-treatment of multinodular nontoxic goiter evaluated by flow volume loop curvesMarked hepatotoxicity associated with losartan treatment[False results on elevated triiodothyronine values in radioimmunoassay]Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?Appearance of Graves'-like disease after radioiodine therapy for toxic as well as non-toxic multinodular goitre
P50
Q22306402-C516DED1-06D2-4894-A5CF-D63860F9883DQ24634099-ECC71569-95B7-44DF-AB49-FDBE2ACDA4BBQ33446687-01558DF7-A405-4B04-AA0A-89B8CB34E115Q33597636-F1D625DF-1EB7-4664-9F0E-8A5A48572F53Q35004147-21C58A21-57A1-421D-B3C6-1B44FCB13DE6Q36472663-79A6CEF9-13D0-4FB9-ABD6-876796E32C95Q36924546-1D7F7B3C-D5C2-4CBC-AE68-E59B52922938Q37081091-16576F96-AE48-417B-B2CA-F9E96D7429D8Q37109006-3AD79D46-6787-4C74-BEFE-C263C710C0CEQ37290870-95CDE229-B7EA-4C9E-BAF3-54C4E7CA8128Q37622289-81A52E09-2134-4313-B342-8E8DB1FF9296Q38420206-C259BEA6-FC90-4314-922D-A7990F28FC22Q38635784-4548AE9B-2030-4A0C-BC6A-7CD939DCEFB2Q38739410-F29B827B-283A-46DF-B6A2-9913A15E4189Q40963570-ECA9FA11-3D4A-4B2D-A42F-AD8022785FB4Q41003814-D95EA9F3-35AC-4F73-AF37-AC88506FC5FBQ42094359-B180765B-2A06-4CBA-B67E-FB5402904EDCQ42916972-3C04837B-582E-4BE7-9C39-1D5F6FA2CC5EQ43295252-4C6AB3B7-0D5E-43C9-A4B8-2BFD451B62DFQ47262091-E8F10156-7A75-4A1D-8D73-73DF552FB0FAQ50796784-9B51A431-C1A1-4721-87DE-11A442A46E85Q52876736-C4592D03-51A6-44D7-BB1B-6BDEF3BD321DQ52903101-70D53813-F53C-4C3C-8A09-70CBC4D93175Q54160048-3419BEEF-71EE-4B07-9DC2-7B27B27E7E08Q57644581-DCFE1908-316E-42CD-B9B4-1C07D5654C0CQ58088645-FC18C4AB-1478-41DF-9DBC-9C01BE20FAEEQ58112259-CABFFCD6-041C-4998-B737-0574C4D54176Q58124610-3D58B35D-0B4D-44A2-941F-9B0C8025B486Q58186625-BBD7EDA0-8DD0-4A8F-BBC0-4899E2525AB4Q59694015-BBEAADD1-7463-4C3B-BF28-6B0555BE628CQ61793896-E62CC1A0-3144-46CA-B3FA-8170DC9D3F4FQ61807145-D62B4704-7605-4FEF-9462-8325374734C8Q62096682-4E2DF6C0-03D4-4283-98AE-A4A6230E6376Q63753898-F9A2FE9D-4923-4534-90EC-2029CF327B28Q70855736-F19C27BF-9116-476A-95BE-B4BB4079A0B2Q71458804-1EA93982-C20B-454E-B774-6EBBC96E328CQ71495775-E8AF7D45-69FE-4F63-ADB9-7EE1709C6379Q71770759-E0814A17-29D6-4694-A61B-7AF2D73104DEQ71808412-6EB17463-3927-43FB-9E95-B9E0A0486962Q71974572-24C5B3C9-4C88-45DF-8387-1E13E6595712
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Birte Nygaard
@ast
Birte Nygaard
@en
Birte Nygaard
@es
Birte Nygaard
@nl
type
label
Birte Nygaard
@ast
Birte Nygaard
@en
Birte Nygaard
@es
Birte Nygaard
@nl
prefLabel
Birte Nygaard
@ast
Birte Nygaard
@en
Birte Nygaard
@es
Birte Nygaard
@nl
P106
P31
P496
0000-0002-9540-4950